Improving diagnosis and treatment of uveitis using advanced technology
Multi-omics Strategies to Improve Clinical Outcomes in Uveitis
This study is looking at ways to better diagnose and understand uveitis, an eye condition that can cause serious problems, by using advanced technology to find out what might be causing it and how your body is reacting, so we can help doctors take better care of patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10856815 on NIH RePORTER |
What this research studies
This research focuses on uveitis, an inflammatory eye disease that can lead to blindness if not treated promptly. It aims to enhance diagnostic methods by utilizing high-throughput sequencing to identify infectious causes of uveitis and understand the host's response. The project will involve global surveillance of pathogens and the analysis of gene expression profiles to predict clinical outcomes. By collaborating with various stakeholders, the research seeks to improve classification, diagnosis, and biomarker identification for better patient management.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with uveitis, particularly those with infectious cases.
Not a fit: Patients with non-infectious forms of uveitis or those who do not have uveitis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and improved treatment strategies for patients with uveitis, potentially reducing the risk of blindness.
How similar studies have performed: Previous research utilizing high-throughput sequencing for infectious disease diagnosis has shown promising results, indicating potential success for this approach in uveitis.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Shantha, Jessica — University of California, San Francisco
- Study coordinator: Shantha, Jessica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.